Association of NAT2 polymorphisms with susceptibility to psoriasis in the Moscow population

Molecular Biology

Volumn 43, Issue 1, 2009, Pages 55-67

  Kozhekbaeva, Zh M ^a   Gra, O A ^a,b   Fadeev, V S ^a   Goldenkova Pavlova, I V ^a   Korsunskaya, I M ^d   Bruskin, S A ^a   Agafonova, E E ^d   Piruzyan, An L ^d   Surzhikov, S A ^b   Nasedkina, T V ^b,c  

^a VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

Author keywords

Acetylation; Diagnostics; Multiplex PCR; Oligonucleotide biochip; Polymorphism; Predisposition; Psoriasis

Indexed keywords

EID: 61349158085     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893309010087     Document Type: Article

References (47)

1. R.G. Langley G.G. Krueger C.E. Griffiths 2005 Psoriasis: Epidemiology, clinical features, and quality of life Ann. Rheum. Dis. 64 18 23
2. A.L. Piruzyan R.M. Abdeev 2006 Molecular genetics of psoriasis Vestn. Ross. Akad. Med. Nauk. 3 33 43
3. A.V. Moshkalov E.N. Imyanitov 2002 Molecular genetic determinants of susceptibility to psoriasis: A review Dermatologiya. 2 3 5
4. F. Capon G. Novelli S. Semprini 1999 Searching for psoriasis susceptibility genes in Italy: Genome scan and evidence for a new locus on chromosome 1 J. Invest. Dermatol. 112 32 35
5. O.V. Makarova T.V. Viktorova D.G. Yanbaeva G.F. Korytina E.V. Yakupova L.K. Karimova 2003 Polymorphism of xenobiotic metabolism genes in workers of a petrochemical plant Genetika. 39 1268 1274
6. Zh.M. Kozhekbaeva A.S. Glotov O.A. Gra I.V. Goldenkova-Pavlova S.A. Bruskin E.E. Agafonova E.V. Markarova R.M. Abdeev I.M. Korsunskaya An.L. Piruzyan V.E. Barsky A.S. Zasedatelev T.V. Nasedkina 2007 Analysis of NAT2 point mutations with biological microchips Mol. Biol. 41 725 733
7. Baranov V.S., Baranova E.V., Ivashchenko T.E., Aseev M.V. 2000. Genom cheloveka i geny "predraspolozhennosti". Vvedenie v prediktivnuyu meditsinu (The Human Genome and "Susceptibility Genes": Introduction to Predictive Medicine), St. Petersburg: Intermedika.
8. I.V. Goldenkova-Pavlova S.A. Bruskin R.M. Abdeev E.V. Markarova S. G. Bigvava L.A. Radkevich Kh.A. Kurdanov Zh.M. Kozhekbaeva A.S. Glotov O.A. Gra A.S. Zasedatelev T.V. Nasedkina E.S. Piruzyan 2006 Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping Genetika. 42 1 8
9. V.A. Vavilin S.I. Makarova V.V. Lyakhovich S.M. Gavalov 2002 Association of the polymorphic genes for xenobiotic biotransformation enzymes with predisposition to bronchial asthma in children with or without hereditary load Genetika. 38 539 545
10. T.V. Viktorova G.F. Korytina O.V. Makarova D.G. Yanbaeva E.V. Yakupova E.K. Khusnutdinova 2003 Analysis of N-acetyltransferase 2 gene polymorphism in patients with chronic obstructive pulomnary disease from populations of the Volga-Ural region Genetika. 39 855 857
11. V.V. Artamonov L.N. Lyubchenko M.A. Shabanov M.V. Nemtsova D.V. Zaletaev 2004 The association of NAT2 polymorphisms with sporadic breast cancer Mol. Biol. 58 457 462
12. V.V. Lyakhovich V.A. Vavilin A.Yu. Grishanova L.F. Gulyaeva S.P. Kovalenkova 2004 Genomic medicine and new approaches to treatment of oncological diseases Byull. Sib. Otd. Ross. Akad. Med. Nauk. 112 20 26
13. J.M. Dupret G.H. Goodfellow S.A. Janezic D.M. Grant 1994 Structure-function studies of human arylamine Nacetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli J. Biol. Chem. 269 26830 26835
14. Rais R. Kh., Gulyaeva L.F. 2003. Biologicheskie effekty toksicheskikh soedinenii. Kurs lektsii (Lectures on Biological Effects of Toxic Compounds), Novosibirsk.
15. A. Hatagima 2002 Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility Cad. Saude Publica. 18 357 377
16. L. Tamer M. Caliko?lu N. Aras Ateş H. Yildirim S. Karakas U. Atik 2006 Relationship between N-acetyltransferase-2 gene polymorphism and risk of bronchial asthma Tuberk. Toraks. 54 137 143
17. L. Tamer A. Yilmaz H. Yildirim L. Ayaz N.A. Ates S. Karakas O. Oz O. Yildirim U. Atik 2005 N-acetyltransferase 2 phenotype may be associated with susceptibility to age-related cataract Curr. Eye Res. 30 835 839
18. J.A. Agúndez J.M. Ladero M. Olivera L. Lozano M. Fernández-Arquero E.G. de la Concha M. Díaz-Rubio J. Benitez 2002 N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease Scand. J. Gastroenterol. 37 99 103
19. T. Luszawska-Kutrzeba 1999 NAT2*genotype in children with bronchial asthma and other atopic diseases Ann. Acad. Med. Stetin. 45 109 121
20. E. Zielińska W. Niewiarowski J. Bodalski A. Stańczyk W. Bolanowski G. Rebowski 1997 Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases Clin. Pharmacol. Ther. 62 635 642
21. S. Ozawa 1997 Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans Yakugaku Zasshi. 117 895 909
22. O.A. Gra A.S. Glotov Zh.M. Kozhekbaeva O.V. Makarova T.V. Nasedkina 2007 Genetic polymorphism of GST, NAT2, and MTRR and presusceptibility to childhood acute leukemia Mol. Biol. 42 1 13
23. M. García-Closas N. Malats D. Silverman M. Dosemeci M. Kogevinas D.W. Hein A. Tardón C. Serra A. Carrato R. García-Closas J. Lloreta G. Castaño-Vinyals M. Yeager R. Welch S. Chanock N. Chatterjee S. Wacholder C. Samanic M. Torá F. Fernández F.X. Real N. Rothman 2005 NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses Lancet. 366 649 659
24. J. Brockmöller I. Cascorbi R. Kerb C. Sachse I. Roots 1998 Polymorphisms in xenobiotic conjugation and disease predisposition Toxicol. Lett. 28 173 183
25. Q.W. Ma G.F. Lin J.G. Chen C.Q. Xiang W.C. Guo K. Golka J.H. Shen 2004 Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in Shanghai population: Occupational and non-occupational bladder cancer patient groups Biomed. Environ. Sci. 17 291 298
26. M.B. Johns J.E. Paulus-Thomas 1989 Purification of human genomic DNA from whole blood using proteinase K treatment followed by phenol-chlorophorm extraction Anal. Biochem. 180 276 278
27. A.S. Glotov T.V. Nasedkina T.E. Ivashchenko R.A. Yurasov S.A. Surzhikov S.V. Pan'kov A.V. Chudinov V.S. Baranov A.S. Zasedatelev 2005 Development of a biochip for analyzing polymorphism of the biotransformation genes Mol. Biol. 39 403 412
28. O.E. Fedorova O.N. Sinitska L.P. Tikhomirova Ya.V. Vishnevskaya A.S. Zasedatelev T.V. Nasedkina 2006 Analysis of point mutations in the BRCA1 gene by hybridization with hydrogel microchips Mol. Biol. 40 31 36
29. O.A. Gra A.S. Glotov E.A. Nikitin O.S. Glotov V.E. Kuznetsova A.V. Chudinov A.B. Sudarikov T.V. Nasedkina 2008 Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients Am. J. Hematol. 83 279 287
30. D.W. Hein M.A. Doll A.J. Fretland M.A. Leff S.J. Webb G.H. Xiao U.-S. Devanaboyina N.A. Nangju Y. Feng 2000 Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol. Biomark. 9 29 42
31. L.X. Shen J.P. Basilion V.P. Stanton Jr. 1999 Single nucleotide polymorphisms can cause different structural folds of mRNA Proc. Natl. Acad. Sci. USA. 96 7871 7876
32. Alfred Kidd, http://alfred.med.yale.edu
33. M.V. Nikishina 2004 Restriction analysis of the N-acetyltransferase gene (NAT2) in caucasoids from western Siberia Genetika. 40 1557 1561
34. N.M. Probst-Hensch R.W. Haile S.A. Ingles M.P. Longnecker C.Y. Han B.K. Lin D.B. Lee G.T. Sakamoto H.D. Frankl E.R. Lee H.J. Lin 1995 Acetylation polymorphism and prevalence of colorectal adenomas Cancer Res. 55 2017 2020
35. http://www.ceps.com.tw/ec/ecjnlarticleView.aspx?atliid =494049&issueiid = 33601&jnliid = 2873
36. E.A. Gaikovitch I. Cascorbi P.M. Mrozikiewicz J. Brockmöller R. Frötschl K. Köpke T. Gerloff J.N. Chernov I. Roots 2003 Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population Eur. J. Clin. Pharmacol. 59 303 312
37. I. Cascorbi N. Drakoulis J. Brockmöller A. Maurer K. Sperling I. Roots 1995 Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity Am. J. Hum. Genet. 57 581 592
38. M. Gross T. Kruisselbrink K. Anderson N. Lang P. [tmp] McGovern R. Delongchamp F. Kadlubar 1999 Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population Cancer Epidemiol. Biomarkers Prev. 8 683 692
39. E.V. Belogubova E.Sh. Kuligina A.V. Togo M.B. Karpova J.M. Ulibina V.A. Shutkin K.P. Hanson K. Popowski I. Mosyagin I. Cascorbi A. Hirvonen E.N. Imyanitov 2005 Comparison of extremes approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility Cancer Lett. 221 177 183
40. M. Soejima T. Sugiura Y. Kawaguchi M. Kawamoto Y. Katsumata K. Takagi A. Nakajima T. Mitamura A. Mimori M. Hara N. Kamatani 2007 Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus Arthritis Res. Ther. 9 1 7
41. S. Rabstein K. Unfried U. Ranft T. Illig M. Kolz H.P. Rihs C. Mambetova M. Vlad T. Brüning B. Pesch 2006 Variation of the N-acetyltransferase 2 gene in a Romanian and a Kyrgyz population Cancer Epidemiol. Biomarkers Prev. 15 138 141
42. E. Patin L.B. Barreiro P.C. Sabeti F. Austerlitz F. Luca A. Sajantila D.M. Behar O. Semino A. Sakuntabhai N. Guiso B. Gicquel K. [tmp] McElreavey R.M. Harding E. Heyer L. Quintana-Murci 2006 Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes Am. J. Hum. Genet. 78 423 436
43. Komarova N.V. 2002. Occupational stress. An essay on the course "Mental Health." http://www.bestreferat.ru/referat-55057.html
44. E. Zielińska W. Niewiarowski J. Bodalski A. Stańczyk W. Bolanowski G. Rebowski 1997 Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases Clin. Pharmacol. Ther. 62 635 642
45. B. Gawrońska-Szklarz T. Luszawska-Kutrzeba G. Czaja-Bulsa G. Kurzawski 1999 Relationship between acetylation polymorphism and risk of atopic diseases Clin. Pharmacol. Ther. 65 562 569
46. I. Gunnarsson L. Kanerud E. Pettersson I. Lundberg S. Lindblad B. Ringertz 1997 Predisposing factors in sulphasalazine-induced systemic lupus erythematosus Br. J. Rheumatol. 36 1089 1094
47. T. Nakajima O. Yamanoshita M. Kamijima R. Kishi G. Ichihara 2003 Generalized skin reactions in relation to trichloroethylene exposure: A review from the viewpoint of drug-metabolizing enzymes J. Occup. Health. 45 8 14